Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.

ABSTRACT: Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course of COVID-19.

SUBMITTER: Saini KS 

PROVIDER: S-EPMC7307309 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature